MedPath

The effect of washing vascular access area to reduce inflammation and infection in hemodialysis patients patients

Phase 2
Conditions
Hemodialysis.
Chronic kidney disease
Registration Number
IRCT2013050913284N1
Lead Sponsor
Vice Chancellor for Research, Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

The main criteria for inclusion: absence of inflammation vascular access area at the start of the project; willingness to cooperate in the investigation; At least 6 months have passed from the start of dialysis; done 2 or 3 times dialysis in week; aged over 18 years; absence of specific diseases such as leukemia, infection, immune deficiency? dermatitis; Do not use anti-inflammatory, immunosuppressive drugs; type of permanent vascular access fistula or cortex (Gore-Tex) in the control arm; ability to perform the necessary Interventions; Patient cooperation in research.
The main criteria for exclusion: fistula or graft failure during the study for any reason other than infection; In the case of renal transplantation or peritoneal dialysis Take place; patient dies; patient withdrew from the partnership plan for any reason; infectious disease in other parts of the body, or for any reason receive antibiotics; fistula or graft inflammation due to trauma, or any other apart from the infection process.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Inflammation. Timepoint: at each hemodialysis session. Method of measurement: Nurses Association criteria for intravenous injection phlebitis.;Infection. Timepoint: at each hemodialysis session. Method of measurement: place access secretion or blood culture.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath